NSEAnalysts/Institutional Investor Meet/Con. Call Updates1d ago · 20 Sept 2026, 11:41 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Supriya Lifescience Limited · SUPRIYA

✦ AI Summaryanalysts_institutional_investo

Supriya Lifescience Limited has informed the Exchange about Schedule of meet for Analyst/Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. The company will be interacting with Analyst/Institutional Investors on September 25, 2026, via a virtual group meeting. The investor presentation is available on the stock exchanges and the company's website.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Supriya Lifescience Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

SUPRIYA_20092026233934_IntimationofMeeting200926.pdf

pdf

Download →
View document text
September 20, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir/Madam, Subject: Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (“Company”) will be interacting with Analyst/Institutional Investors as per details below: Sr. Meeting with Date & Time Format Mode 1. Investors Group Meeting Friday, September 25, 2026 Group Meeting Virtual 11:00 AM – 12:00 Noon. This is to further inform you that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company’s website www.supriyalifescience.com for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Note: The above date is subject to change. Change may happen due to exigencies on the part of the Company or Analyst/Investor/Fund. Request you to kindly take the same on record. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE